Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-001808
Filing Date
2025-01-24
Accepted
2025-01-24 16:18:52
Documents
1
Period of Report
2025-01-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3200
  Complete submission text file 0001437749-25-001808.txt   4620
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Issuer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IN8BIO, INC. 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address
Graff Jeremy R. (Reporting) CIK: 0001975028 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41160 | Film No.: 25554462